Cytomegalovirus Infection in Transplant Recipients
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection in Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir [Phase 3]
Phase 3 trial assessing efficacy and safety of maribavir versus investigator-assigned treatment for CMV infections refractory or resistant t…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: A Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valganciclovir (Valcyte®) Versus Untreated Matched Controls [Phase 4]
Phase 4 clinical trial comparing spermatogenesis outcomes in male renal transplant recipients treated with valganciclovir (Valcyte) versus u…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients [Phase 2]
Phase 2 trial investigating maribavir for resistant or refractory CMV infections in transplant recipients has completed with results posted.